Replies to post #367 on RedHill Biopharma Ltd (RDHL)

[Amatuer17]

It is interesting company - clean balance sheet - good cash on hand ($47 million), good mgmt team, the presentation and the information is very clean
Above all - the list of products in P2 and P3 is really long and promising
Good patent protection and combination of 505b and new products.

Seems they think they can get higher price at later date. In conf call, the intention was - if the Q2-2017 DSMB results are good look for partnership for Crohn's - so seems they want to go for partnership based on product - not all out sell of company.
Either way - execute well and investors will benefit.